Global Niacin and Niacinamide Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Niacin and Niacinamide market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Niacin and Niacinamide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Niacin and Niacinamide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Niacin and Niacinamide market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Niacin and Niacinamide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Niacin and Niacinamide market include Zhejiang Lanbo Biotechnology, Merck, Lonza, Vertellus Specialties, Vanetta, Vanetta, Lasons India, Koninklijke and Jubilant Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Niacin and Niacinamide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Niacin and Niacinamide, also provides the sales of main regions and countries. Of the upcoming market potential for Niacin and Niacinamide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Niacin and Niacinamide sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Niacin and Niacinamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Niacin and Niacinamide sales, projected growth trends, production technology, application and end-user industry.
Niacin and Niacinamide Segment by Company
Zhejiang Lanbo Biotechnology
Merck
Lonza
Vertellus Specialties
Vanetta
Vanetta
Lasons India
Koninklijke
Jubilant Life Sciences
Foodchem
Fagron
Evonik
DSM
Brother Enterprises
BASF
Bactolac
Niacin and Niacinamide Segment by Type
Powder Niacin and Niacinamide
Granular Niacin and Niacinamide
Liquid Niacin and Niacinamide
Niacin and Niacinamide Segment by Application
Cosmeceuticals
Pharmaceuticals
Human Nutrition
Animal Nutrition
Others
Niacin and Niacinamide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Niacin and Niacinamide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Niacin and Niacinamide market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Niacin and Niacinamide significant trends, drivers, influence factors in global and regions.
6. To analyze Niacin and Niacinamide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niacin and Niacinamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Niacin and Niacinamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niacin and Niacinamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Niacin and Niacinamide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Niacin and Niacinamide industry.
Chapter 3: Detailed analysis of Niacin and Niacinamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Niacin and Niacinamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Niacin and Niacinamide in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Niacin and Niacinamide market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Niacin and Niacinamide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Niacin and Niacinamide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Niacin and Niacinamide market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Niacin and Niacinamide is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Niacin and Niacinamide market include Zhejiang Lanbo Biotechnology, Merck, Lonza, Vertellus Specialties, Vanetta, Vanetta, Lasons India, Koninklijke and Jubilant Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Niacin and Niacinamide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Niacin and Niacinamide, also provides the sales of main regions and countries. Of the upcoming market potential for Niacin and Niacinamide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Niacin and Niacinamide sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Niacin and Niacinamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Niacin and Niacinamide sales, projected growth trends, production technology, application and end-user industry.
Niacin and Niacinamide Segment by Company
Zhejiang Lanbo Biotechnology
Merck
Lonza
Vertellus Specialties
Vanetta
Vanetta
Lasons India
Koninklijke
Jubilant Life Sciences
Foodchem
Fagron
Evonik
DSM
Brother Enterprises
BASF
Bactolac
Niacin and Niacinamide Segment by Type
Powder Niacin and Niacinamide
Granular Niacin and Niacinamide
Liquid Niacin and Niacinamide
Niacin and Niacinamide Segment by Application
Cosmeceuticals
Pharmaceuticals
Human Nutrition
Animal Nutrition
Others
Niacin and Niacinamide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Niacin and Niacinamide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Niacin and Niacinamide market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Niacin and Niacinamide significant trends, drivers, influence factors in global and regions.
6. To analyze Niacin and Niacinamide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niacin and Niacinamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Niacin and Niacinamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niacin and Niacinamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Niacin and Niacinamide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Niacin and Niacinamide industry.
Chapter 3: Detailed analysis of Niacin and Niacinamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Niacin and Niacinamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Niacin and Niacinamide in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note:Â Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
207 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Niacin and Niacinamide Sales Value (2020-2031)
- 1.2.2 Global Niacin and Niacinamide Sales Volume (2020-2031)
- 1.2.3 Global Niacin and Niacinamide Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Niacin and Niacinamide Market Dynamics
- 2.1 Niacin and Niacinamide Industry Trends
- 2.2 Niacin and Niacinamide Industry Drivers
- 2.3 Niacin and Niacinamide Industry Opportunities and Challenges
- 2.4 Niacin and Niacinamide Industry Restraints
- 3 Niacin and Niacinamide Market by Company
- 3.1 Global Niacin and Niacinamide Company Revenue Ranking in 2024
- 3.2 Global Niacin and Niacinamide Revenue by Company (2020-2025)
- 3.3 Global Niacin and Niacinamide Sales Volume by Company (2020-2025)
- 3.4 Global Niacin and Niacinamide Average Price by Company (2020-2025)
- 3.5 Global Niacin and Niacinamide Company Ranking (2023-2025)
- 3.6 Global Niacin and Niacinamide Company Manufacturing Base and Headquarters
- 3.7 Global Niacin and Niacinamide Company Product Type and Application
- 3.8 Global Niacin and Niacinamide Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Niacin and Niacinamide Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Niacin and Niacinamide Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Niacin and Niacinamide Market by Type
- 4.1 Niacin and Niacinamide Type Introduction
- 4.1.1 Powder Niacin and Niacinamide
- 4.1.2 Granular Niacin and Niacinamide
- 4.1.3 Liquid Niacin and Niacinamide
- 4.2 Global Niacin and Niacinamide Sales Volume by Type
- 4.2.1 Global Niacin and Niacinamide Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Niacin and Niacinamide Sales Volume by Type (2020-2031)
- 4.2.3 Global Niacin and Niacinamide Sales Volume Share by Type (2020-2031)
- 4.3 Global Niacin and Niacinamide Sales Value by Type
- 4.3.1 Global Niacin and Niacinamide Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Niacin and Niacinamide Sales Value by Type (2020-2031)
- 4.3.3 Global Niacin and Niacinamide Sales Value Share by Type (2020-2031)
- 5 Niacin and Niacinamide Market by Application
- 5.1 Niacin and Niacinamide Application Introduction
- 5.1.1 Cosmeceuticals
- 5.1.2 Pharmaceuticals
- 5.1.3 Human Nutrition
- 5.1.4 Animal Nutrition
- 5.1.5 Others
- 5.2 Global Niacin and Niacinamide Sales Volume by Application
- 5.2.1 Global Niacin and Niacinamide Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Niacin and Niacinamide Sales Volume by Application (2020-2031)
- 5.2.3 Global Niacin and Niacinamide Sales Volume Share by Application (2020-2031)
- 5.3 Global Niacin and Niacinamide Sales Value by Application
- 5.3.1 Global Niacin and Niacinamide Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Niacin and Niacinamide Sales Value by Application (2020-2031)
- 5.3.3 Global Niacin and Niacinamide Sales Value Share by Application (2020-2031)
- 6 Niacin and Niacinamide Regional Sales and Value Analysis
- 6.1 Global Niacin and Niacinamide Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Niacin and Niacinamide Sales by Region (2020-2031)
- 6.2.1 Global Niacin and Niacinamide Sales by Region: 2020-2025
- 6.2.2 Global Niacin and Niacinamide Sales by Region (2026-2031)
- 6.3 Global Niacin and Niacinamide Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Niacin and Niacinamide Sales Value by Region (2020-2031)
- 6.4.1 Global Niacin and Niacinamide Sales Value by Region: 2020-2025
- 6.4.2 Global Niacin and Niacinamide Sales Value by Region (2026-2031)
- 6.5 Global Niacin and Niacinamide Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Niacin and Niacinamide Sales Value (2020-2031)
- 6.6.2 North America Niacin and Niacinamide Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Niacin and Niacinamide Sales Value (2020-2031)
- 6.7.2 Europe Niacin and Niacinamide Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Niacin and Niacinamide Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Niacin and Niacinamide Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Niacin and Niacinamide Sales Value (2020-2031)
- 6.9.2 South America Niacin and Niacinamide Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Niacin and Niacinamide Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Niacin and Niacinamide Sales Value Share by Country, 2024 VS 2031
- 7 Niacin and Niacinamide Country-level Sales and Value Analysis
- 7.1 Global Niacin and Niacinamide Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Niacin and Niacinamide Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Niacin and Niacinamide Sales by Country (2020-2031)
- 7.3.1 Global Niacin and Niacinamide Sales by Country (2020-2025)
- 7.3.2 Global Niacin and Niacinamide Sales by Country (2026-2031)
- 7.4 Global Niacin and Niacinamide Sales Value by Country (2020-2031)
- 7.4.1 Global Niacin and Niacinamide Sales Value by Country (2020-2025)
- 7.4.2 Global Niacin and Niacinamide Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.9.2 France Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.16.2 China Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.19.2 India Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Niacin and Niacinamide Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Niacin and Niacinamide Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Niacin and Niacinamide Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Zhejiang Lanbo Biotechnology
- 8.1.1 Zhejiang Lanbo Biotechnology Comapny Information
- 8.1.2 Zhejiang Lanbo Biotechnology Business Overview
- 8.1.3 Zhejiang Lanbo Biotechnology Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Zhejiang Lanbo Biotechnology Niacin and Niacinamide Product Portfolio
- 8.1.5 Zhejiang Lanbo Biotechnology Recent Developments
- 8.2 Merck
- 8.2.1 Merck Comapny Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Merck Niacin and Niacinamide Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 Lonza
- 8.3.1 Lonza Comapny Information
- 8.3.2 Lonza Business Overview
- 8.3.3 Lonza Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Lonza Niacin and Niacinamide Product Portfolio
- 8.3.5 Lonza Recent Developments
- 8.4 Vertellus Specialties
- 8.4.1 Vertellus Specialties Comapny Information
- 8.4.2 Vertellus Specialties Business Overview
- 8.4.3 Vertellus Specialties Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Vertellus Specialties Niacin and Niacinamide Product Portfolio
- 8.4.5 Vertellus Specialties Recent Developments
- 8.5 Vanetta
- 8.5.1 Vanetta Comapny Information
- 8.5.2 Vanetta Business Overview
- 8.5.3 Vanetta Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Vanetta Niacin and Niacinamide Product Portfolio
- 8.5.5 Vanetta Recent Developments
- 8.6 Vanetta
- 8.6.1 Vanetta Comapny Information
- 8.6.2 Vanetta Business Overview
- 8.6.3 Vanetta Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Vanetta Niacin and Niacinamide Product Portfolio
- 8.6.5 Vanetta Recent Developments
- 8.7 Lasons India
- 8.7.1 Lasons India Comapny Information
- 8.7.2 Lasons India Business Overview
- 8.7.3 Lasons India Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Lasons India Niacin and Niacinamide Product Portfolio
- 8.7.5 Lasons India Recent Developments
- 8.8 Koninklijke
- 8.8.1 Koninklijke Comapny Information
- 8.8.2 Koninklijke Business Overview
- 8.8.3 Koninklijke Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.8.4 Koninklijke Niacin and Niacinamide Product Portfolio
- 8.8.5 Koninklijke Recent Developments
- 8.9 Jubilant Life Sciences
- 8.9.1 Jubilant Life Sciences Comapny Information
- 8.9.2 Jubilant Life Sciences Business Overview
- 8.9.3 Jubilant Life Sciences Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.9.4 Jubilant Life Sciences Niacin and Niacinamide Product Portfolio
- 8.9.5 Jubilant Life Sciences Recent Developments
- 8.10 Foodchem
- 8.10.1 Foodchem Comapny Information
- 8.10.2 Foodchem Business Overview
- 8.10.3 Foodchem Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.10.4 Foodchem Niacin and Niacinamide Product Portfolio
- 8.10.5 Foodchem Recent Developments
- 8.11 Fagron
- 8.11.1 Fagron Comapny Information
- 8.11.2 Fagron Business Overview
- 8.11.3 Fagron Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.11.4 Fagron Niacin and Niacinamide Product Portfolio
- 8.11.5 Fagron Recent Developments
- 8.12 Evonik
- 8.12.1 Evonik Comapny Information
- 8.12.2 Evonik Business Overview
- 8.12.3 Evonik Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.12.4 Evonik Niacin and Niacinamide Product Portfolio
- 8.12.5 Evonik Recent Developments
- 8.13 DSM
- 8.13.1 DSM Comapny Information
- 8.13.2 DSM Business Overview
- 8.13.3 DSM Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.13.4 DSM Niacin and Niacinamide Product Portfolio
- 8.13.5 DSM Recent Developments
- 8.14 Brother Enterprises
- 8.14.1 Brother Enterprises Comapny Information
- 8.14.2 Brother Enterprises Business Overview
- 8.14.3 Brother Enterprises Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.14.4 Brother Enterprises Niacin and Niacinamide Product Portfolio
- 8.14.5 Brother Enterprises Recent Developments
- 8.15 BASF
- 8.15.1 BASF Comapny Information
- 8.15.2 BASF Business Overview
- 8.15.3 BASF Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.15.4 BASF Niacin and Niacinamide Product Portfolio
- 8.15.5 BASF Recent Developments
- 8.16 Bactolac
- 8.16.1 Bactolac Comapny Information
- 8.16.2 Bactolac Business Overview
- 8.16.3 Bactolac Niacin and Niacinamide Sales, Value and Gross Margin (2020-2025)
- 8.16.4 Bactolac Niacin and Niacinamide Product Portfolio
- 8.16.5 Bactolac Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Niacin and Niacinamide Value Chain Analysis
- 9.1.1 Niacin and Niacinamide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Niacin and Niacinamide Sales Mode & Process
- 9.2 Niacin and Niacinamide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Niacin and Niacinamide Distributors
- 9.2.3 Niacin and Niacinamide Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


